Published in J Pediatr on April 24, 2009
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol (2012) 1.56
Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation. Haematologica (2011) 1.02
Native nephrectomy prior to pediatric kidney transplantation: biological and clinical aspects. Pediatr Nephrol (2012) 0.99
Current and future management of pediatric venous thromboembolism. Am J Hematol (2012) 0.91
Case series of thromboembolic complications in childhood nephrotic syndrome: Hacettepe experience. Clin Exp Nephrol (2014) 0.91
Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality. Pediatr Nephrol (2014) 0.88
Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study. BMC Nephrol (2012) 0.83
Chapter 4: Steroid-resistant nephrotic syndrome in children. Kidney Int Suppl (2011) (2012) 0.81
Healthcare burden of venous thromboembolism in childhood chronic renal diseases. Pediatr Nephrol (2014) 0.79
Bilateral iliac and popliteal arterial thrombosis in a child with focal segmental glomerulosclerosis. Korean J Pediatr (2016) 0.78
Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol (2013) 0.78
The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol (2015) 0.77
Platelet abnormalities in nephrotic syndrome. Pediatr Nephrol (2015) 0.76
The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications. Pediatr Nephrol (2013) 0.76
Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy. Clin Exp Nephrol (2015) 0.76
Nephrosis and clots. J Pediatr (2009) 0.76
Benign acute childhood myositis complicating influenza B infection in a boy with idiopathic nephrotic syndrome. Cent Eur J Immunol (2016) 0.75
Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome. J Am Soc Nephrol (2015) 0.75
Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency. Ital J Pediatr (2016) 0.75
The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse. Ital J Pediatr (2017) 0.75
Thrombosis of the Abdominal Veins in Childhood. Front Pediatr (2017) 0.75
Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy. Pediatr Nephrol (2011) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77
Nephrotic syndrome in childhood. Lancet (2003) 3.36
The nephrotic syndrome. N Engl J Med (1998) 3.22
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood (1994) 2.14
Congenital nephrotic syndrome: evolution of medical management and results of renal transplantation. J Pediatr (1984) 1.82
Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr (2004) 1.46
Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort. Ann Rheum Dis (2008) 1.38
Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974-1996). Pediatr Nephrol (2000) 1.20
Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta Paediatr Scand (1986) 1.10
Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. J Pediatr (1980) 1.07
Clinical significance of lupus anticoagulants in children. J Pediatr (1999) 1.07
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum (2005) 1.05
Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thromb Haemost (1999) 1.02
Hemostatic complications in renal disorders of the young. Pediatr Nephrol (1996) 0.95
Thromboembolic risks and complications in nephrotic children. Semin Thromb Hemost (1997) 0.95
Thromboembolism in childhood nephrotic syndrome: a rare but serious complication. Hematology (2007) 0.92
Thrombotic complications in childhood-onset idiopathic membranous nephropathy. Pediatr Nephrol (2003) 0.89
Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome. Pediatr Nephrol (2006) 0.87
Low protein Z levels in children with nephrotic syndrome. Pediatr Nephrol (2006) 0.86
Increased aggregation with normal surface charge and deformability of red blood cells in children with nephrotic syndrome. Clin Nephrol (1992) 0.84
The antiphospholipid syndrome. Hematology (2005) 0.84
Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease. Pediatr Res (1993) 0.83
Systemic lupus erythematosus in children and adolescents. Pediatr Rev (2006) 0.80
Detection of antiphospholipid antibodies in children and adolescents. Pediatr Hematol Oncol (1998) 0.80
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia. J Clin Oncol (2008) 2.79
Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis (2009) 2.65
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway. Blood (2009) 2.39
Challenges for multilevel health disparities research in a transdisciplinary environment. Am J Prev Med (2008) 2.17
Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy. Crit Care Med (2012) 1.99
Management of childhood onset nephrotic syndrome. Pediatrics (2009) 1.87
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood (2009) 1.83
Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol (2010) 1.81
Weight-based determination of fluid overload status and mortality in pediatric intensive care unit patients requiring continuous renal replacement therapy. Intensive Care Med (2011) 1.79
Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic. Pediatrics (2008) 1.69
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood (2007) 1.69
The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines. Clin Cancer Res (2007) 1.66
Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int (2005) 1.59
Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol (2006) 1.58
Fluid Overload Is Associated With Late Poor Outcomes in Neonates Following Cardiac Surgery. Pediatr Crit Care Med (2016) 1.56
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol (2012) 1.56
Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int (2012) 1.52
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood (2007) 1.51
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma. Ann Surg Oncol (2007) 1.49
Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study. Menopause (2015) 1.45
Chronic stress and susceptibility to skin cancer. J Natl Cancer Inst (2005) 1.41
Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium. Pediatr Nephrol (2013) 1.39
Hemodialysis for near-fatal sodium phosphate toxicity in a child receiving sodium phosphate enemas. Pediatr Emerg Care (2014) 1.39
Update in medical education for pediatrics: insights and directions from the 2010 literature. Med Educ Online (2012) 1.38
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease. J Clin Invest (2014) 1.38
Herbal weight-loss supplement misadventures per a regional poison center. Ann Pharmacother (2004) 1.38
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood (2011) 1.37
Significance of hemolysis on extracorporeal life support after cardiac surgery in children. Pediatr Nephrol (2008) 1.34
Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol (2006) 1.34
ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol. Blood (2012) 1.27
Techniques for handling missing data in secondary analyses of large surveys. Acad Pediatr (2010) 1.26
Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma. Blood (2008) 1.26
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody. Blood (2009) 1.25
IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production. J Immunol (2011) 1.25
IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol (2007) 1.23
The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation. Pharmacogenetics (2004) 1.21
Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population. Intensive Care Med (2014) 1.18
Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2. Carcinogenesis (2007) 1.17
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents. Clin Cancer Res (2008) 1.17
Increased urinary excretion of nephrin, podocalyxin, and βig-h3 in women with preeclampsia. Am J Physiol Renal Physiol (2012) 1.17
Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol (2009) 1.16
Enhanced hemolysis in pediatric patients requiring extracorporeal membrane oxygenation and continuous renal replacement therapy. Ann Thorac Cardiovasc Surg (2007) 1.15
A six-gene phylogeny reveals the evolution of mode of infection in the rice blast fungus and allied species. Mycologia (2011) 1.11
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells. AAPS J (2011) 1.11
The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo. PLoS One (2010) 1.11
IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol (2013) 1.10
Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am J Clin Nutr (2010) 1.10
Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int (2011) 1.09
Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies. Am J Physiol Endocrinol Metab (2012) 1.09
Pediatric chronic kidney disease and the process of health care transition. Semin Nephrol (2009) 1.08
Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol (2008) 1.08
Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Hum Pathol (2006) 1.06
Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease. PLoS One (2013) 1.06
Fluid overload in infants following congenital heart surgery. Pediatr Crit Care Med (2013) 1.04
Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol. Clin Cancer Res (2012) 1.04
A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients. Clin J Am Soc Nephrol (2007) 1.04
Pharmacologic treatment of chronic pediatric hypertension. Paediatr Drugs (2005) 1.04
Deep RNA-Seq uncovers the peach transcriptome landscape. Plant Mol Biol (2013) 1.03
Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI. Eur J Radiol (2011) 1.03
Childhood nephrotic syndrome--current and future therapies. Nat Rev Nephrol (2012) 1.02
Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy. Clin Cancer Res (2006) 1.00
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cells. Clin Cancer Res (2013) 0.99
Genetic testing in nephrotic syndrome--challenges and opportunities. Nat Rev Nephrol (2013) 0.99
Beclin 1 expression is an independent prognostic factor for gastric carcinomas. Tumour Biol (2013) 0.98
Secretome diversity and quantitative analysis of cellulolytic Aspergillus fumigatus Z5 in the presence of different carbon sources. Biotechnol Biofuels (2013) 0.98
Protein encapsulation in mesoporous silicate: the effects of confinement on protein stability, hydration, and volumetric properties. J Am Chem Soc (2004) 0.98
Fellows as teachers: a model to enhance pediatric resident education. Med Educ Online (2011) 0.98
Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas. Oncol Lett (2013) 0.97
2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine-induced DNA adducts and genotoxicity in chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2. Mol Carcinog (2007) 0.97
Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes. Kidney Int (2005) 0.97
Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health Qual Life Outcomes (2013) 0.96
Population pharmacokinetics of amlodipine in hypertensive children and adolescents. J Clin Pharmacol (2006) 0.96
Modulation of sodium/iodide symporter expression in the salivary gland. Thyroid (2013) 0.96
Body mass index in primary and secondary pediatric hypertension. Pediatr Nephrol (2004) 0.95
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia. Br J Haematol (2009) 0.95
Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2014) 0.94
Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells. Blood (2006) 0.94
Factors influencing pediatric nephrology trainee entry into the workforce. Clin J Am Soc Nephrol (2010) 0.94
Deliberate practice improves pediatric residents' skills and team behaviors during simulated neonatal resuscitation. Clin Pediatr (Phila) (2013) 0.94
2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline-induced DNA adduct formation and mutagenesis in DNA repair-deficient Chinese hamster ovary cells expressing human cytochrome P4501A1 and rapid or slow acetylator N-acetyltransferase 2. Cancer Epidemiol Biomarkers Prev (2007) 0.93
Dose- and time-dependent glucocorticoid receptor signaling in podocytes. Am J Physiol Renal Physiol (2010) 0.93
Malignant transformation of infantile hemangioma to angiosarcoma: response to chemotherapy with bevacizumab. Pediatr Blood Cancer (2014) 0.92
Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside. Kidney Int (2004) 0.92
Identification, characterization, and utilization of genome-wide simple sequence repeats to identify a QTL for acidity in apple. BMC Genomics (2012) 0.92
Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis. Nephrol Dial Transplant (2008) 0.92
Thromboembolic events during continuous vasopressin infusions: a retrospective evaluation. Ann Pharmacother (2007) 0.91
Prevalence of sleep disturbances in children and adolescents with chronic kidney disease. Pediatr Nephrol (2011) 0.90
Stability of cefazolin sodium in four heparinized and non-heparinized dialysate solutions at 38 degrees C. Perit Dial Int (2006) 0.90
The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells. PLoS One (2013) 0.90
Meeting the demand for pediatric clinical trials. Sci Transl Med (2014) 0.90
Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy. Muscle Nerve (2009) 0.89
FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways. Blood (2006) 0.89
Clinical trial of extended-release felodipine in pediatric essential hypertension. Pediatr Nephrol (2003) 0.89
Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2. Pharmacogenet Genomics (2007) 0.89
Statins and breast cancer stage and mortality in the Women's Health Initiative. Cancer Causes Control (2015) 0.89